Vivanza Biosciences Ltd

πŸ“Š Vivanza Biosciences Q3 FY26 Results Meeting Scheduled

β€’ Board meeting scheduled for February 12, 2026

β€’ Agenda includes approval of unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025

β€’ Trading window for insiders (directors, officers, key personnel) is closed until 48 hours after results declaration